Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 May;100(5):894-896.
doi: 10.1002/ajh.27514. Epub 2024 Nov 1.

Ibrutinib-related stellar hematomas of the palms and soles

Affiliations
Case Reports

Ibrutinib-related stellar hematomas of the palms and soles

Naia Oillarburu et al. Am J Hematol. 2025 May.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Sibaud V, Beylot‐Barry M, Protin C, Vigarios E, Recher C, Ysebaert L. Dermatological toxicities of Bruton's tyrosine kinase inhibitors. Am J Clin Dermatol. 2020;21(6):799‐812.
    1. Singer S, Tan SY, Dewan AK, et al. Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse events. J Am Acad Dermatol. 2023;88(6):1271‐1281.
    1. Nocco S, Andriano TM, Bose A, et al. Ibrutinib‐associated dermatologic toxicities: a systematic review and meta‐analysis. Crit Rev Oncol Hematol. 2022;174:103696.
    1. Pileri A, Guglielmo A, Agostinelli C, et al. Cutaneous adverse‐events in patients treated with ibrutinib. Dermatol Ther. 2020;33(6):e14190.
    1. Levade M, David E, Garcia C, et al. Ibrutinib treatment affects collagen and von Willebrand factor‐dependent platelet functions. Blood. 2014;124(26):3991‐3995.

Publication types

LinkOut - more resources